This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. plunged 10.2% to $2.38 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 22,141.10 and the Dow Jones Industrial Average falling 0.6% to 45,834.22.
Inovio Pharmaceuticals Inc. closed 66.0% below its 52-week high of $7.00, which the company reached on September 19th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.2% to $178.06, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 3.98% to $23.87.
Trading volume totaled 2.4 million, compared to the 50-day average of 2.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 12, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.